 |
|
A giant trichoblastic carcinoma
Joon Seok Lee, Joon Hyun Kwon, Gyu Sik Jung, Jeong Woo Lee, Jung Dug Yang, Ho Yun Chung, Byung Chae Cho, Kang Young Choi
Arch Craniofac Surg. 2018;19(4):275-278. Published online 2018 Dec 27 DOI: https://doi.org/10.7181/acfs.2018.02124
|
|
Citations to this article as recorded by
 Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas
E. Toulemonde, S. Chevret, M. Battistella, E. M. Neidhardt, C. Nardin, F. Le Du, N. Meyer, M. Véron, L. Gambotti, A. Lamrani-Ghaouti, P. Jamme, C. Chaffaut, M. De Pontville, E. Saada-Bouzid, M. Beylot-Barry, C. Simon, T. Jouary, A. Marabelle, L. Mortier
Cancer Immunology, Immunotherapy.2023; 72(8): 2649. CrossRef Trichoblastic carcinoma: a comprehensive review of the literature
Michelle A. Boettler, Kathryn T. Shahwan, Nadia Y. Abidi, David R. Carr
Archives of Dermatological Research.2022; 314(5): 399. CrossRef Clinicopathological features of trichoblastomas and malignant variant: trichoblastic carcinoma
Melekber CAVUS OZKAN, Zeliha Leyla CINEL
Marmara Medical Journal.2021; 34(2): 147. CrossRef Trichoblastic Carcinoma of the Scalp: a Case Report on a Rare Condition
Jaydeep Malakar, Devajit Choudhury, Soham Som, Mitrajit Sharma
Indian Journal of Surgery.2020; 82(4): 714. CrossRef Don’t Judge a Tumor by Its Biopsy!
Mia Demant, Iselin Saltvig, Hannah Trøstrup, Volker J. Schmidt, Jørgen Hesselfeldt
Case Reports in Dermatology.2020; 12(3): 266. CrossRef
|